Cargando…
Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis
BACKGROUND: The clinical and histologic appearance of fibrosis in cutaneous lesions in chronic graft-versus -host disease (c-GVHD) resembles the appearance of fibrosis in scleroderma (SSc). Recent studies identified distinctive structural changes in the superficial dermal microvasculature and matrix...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705674/ https://www.ncbi.nlm.nih.gov/pubmed/19587802 http://dx.doi.org/10.1371/journal.pone.0006203 |
_version_ | 1782169015656906752 |
---|---|
author | Fleming, Jo Nadine Shulman, Howard M. Nash, Richard A. Johnson, Pamela Y. Wight, Thomas N. Gown, Allen Schwartz, Stephen M. |
author_facet | Fleming, Jo Nadine Shulman, Howard M. Nash, Richard A. Johnson, Pamela Y. Wight, Thomas N. Gown, Allen Schwartz, Stephen M. |
author_sort | Fleming, Jo Nadine |
collection | PubMed |
description | BACKGROUND: The clinical and histologic appearance of fibrosis in cutaneous lesions in chronic graft-versus -host disease (c-GVHD) resembles the appearance of fibrosis in scleroderma (SSc). Recent studies identified distinctive structural changes in the superficial dermal microvasculature and matrix of SSc skin. We compared the dermal microvasculature in human c-GVHD to SSc to determine if c-GVHD is a suitable model for SSc. METHODOLOGY/PRINCIPAL FINDINGS: We analyzed skin biopsies of normal controls (n = 24), patients with SSc (n = 30) and c-GVHD with dermal fibrosis (n = 133)). Immunostaining was employed to identify vessels, vascular smooth muscle, dermal matrix, and cell proliferation. C-GVHD and SSc had similar dermal matrix composition and vascular smooth muscle pathology, including intimal hyperplasia. SSc, however, differed significantly from c-GVHD in three ways. First, there were significantly fewer (p = 0.00001) average vessels in SSc biopsies (9.8) when compared with c-GVHD (16.5). Second, in SSc, endothelial markers were decreased significantly (19/19 and 12/14 for VE cadherin and vWF (p = <0.0001 and <0.05), respectively). In contrast, 0/13 c-GVHD biopsies showed loss of staining with canonical endothelial markers. Third, c-GVHD contained areas of microvascular endothelial proliferation not present in the SSc biopsies. CONCLUSIONS/SIGNIFICANCE: The sclerosis associated with c-GVHD appears to resemble wound healing. Focal capillary proliferation occurs in early c-GVHD. In contrast, loss of canonical endothelial markers and dermal capillaries is seen in SSc, but not in c-GVHD. The loss of VE cadherin in SSc, in particular, may be related to microvascular rarefaction because VE cadherin is necessary for angiogenesis. C-GVHD is a suitable model for studying dermal fibrosis but may not be applicable for studying the microvascular alterations characteristic of SSc. |
format | Text |
id | pubmed-2705674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-27056742009-07-09 Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis Fleming, Jo Nadine Shulman, Howard M. Nash, Richard A. Johnson, Pamela Y. Wight, Thomas N. Gown, Allen Schwartz, Stephen M. PLoS One Research Article BACKGROUND: The clinical and histologic appearance of fibrosis in cutaneous lesions in chronic graft-versus -host disease (c-GVHD) resembles the appearance of fibrosis in scleroderma (SSc). Recent studies identified distinctive structural changes in the superficial dermal microvasculature and matrix of SSc skin. We compared the dermal microvasculature in human c-GVHD to SSc to determine if c-GVHD is a suitable model for SSc. METHODOLOGY/PRINCIPAL FINDINGS: We analyzed skin biopsies of normal controls (n = 24), patients with SSc (n = 30) and c-GVHD with dermal fibrosis (n = 133)). Immunostaining was employed to identify vessels, vascular smooth muscle, dermal matrix, and cell proliferation. C-GVHD and SSc had similar dermal matrix composition and vascular smooth muscle pathology, including intimal hyperplasia. SSc, however, differed significantly from c-GVHD in three ways. First, there were significantly fewer (p = 0.00001) average vessels in SSc biopsies (9.8) when compared with c-GVHD (16.5). Second, in SSc, endothelial markers were decreased significantly (19/19 and 12/14 for VE cadherin and vWF (p = <0.0001 and <0.05), respectively). In contrast, 0/13 c-GVHD biopsies showed loss of staining with canonical endothelial markers. Third, c-GVHD contained areas of microvascular endothelial proliferation not present in the SSc biopsies. CONCLUSIONS/SIGNIFICANCE: The sclerosis associated with c-GVHD appears to resemble wound healing. Focal capillary proliferation occurs in early c-GVHD. In contrast, loss of canonical endothelial markers and dermal capillaries is seen in SSc, but not in c-GVHD. The loss of VE cadherin in SSc, in particular, may be related to microvascular rarefaction because VE cadherin is necessary for angiogenesis. C-GVHD is a suitable model for studying dermal fibrosis but may not be applicable for studying the microvascular alterations characteristic of SSc. Public Library of Science 2009-07-09 /pmc/articles/PMC2705674/ /pubmed/19587802 http://dx.doi.org/10.1371/journal.pone.0006203 Text en Fleming et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Fleming, Jo Nadine Shulman, Howard M. Nash, Richard A. Johnson, Pamela Y. Wight, Thomas N. Gown, Allen Schwartz, Stephen M. Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis |
title | Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis |
title_full | Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis |
title_fullStr | Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis |
title_full_unstemmed | Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis |
title_short | Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis |
title_sort | cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705674/ https://www.ncbi.nlm.nih.gov/pubmed/19587802 http://dx.doi.org/10.1371/journal.pone.0006203 |
work_keys_str_mv | AT flemingjonadine cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis AT shulmanhowardm cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis AT nashricharda cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis AT johnsonpamelay cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis AT wightthomasn cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis AT gownallen cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis AT schwartzstephenm cutaneouschronicgraftversushostdiseasedoesnothavetheabnormalendothelialphenotypeorvascularrarefactioncharacteristicofsystemicsclerosis |